Many patients begin to notice appetite changes within the first 12 weeks, with more visible progress developing over the following months
Actual results may differ materially from those contemplated by the forward-looking statements due to the risks and uncertainties described in CVS Healths filings with the Securities and Exchange Commission, including those set forth in the Risk Factors section and under the heading Cautionary Statement Concerning Forward-Looking Statements in our most recent Annual Report on Form 10-K, Quarterly Report on Form 10-Q, and Current Reports on Form 8-K
Following its June 2026 approval, it is rolling out on private prescription during the second half of 2026 and is not available on the NHS
AOD9604 Side Effects and Safety Profile AOD9604 is often marketed as a safe, sideeffectfree fat burner, but like any peptide, its safety profile depends on dosage, individual response, and overall health status
People with pre-existing structural issues in the gut, such as strictures or motility disorders, can be at risk if fiber is added suddenly
.png)
